Close Menu

NEW YORK – Oxford Immunotec said on Wednesday it has begun a collaboration with specialty vaccine firm Valneva to perform T-cell testing on participants receiving Valneva's COVID-19 vaccine candidate in a study.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.